FGFR2 amplification in colorectal adenocarcinoma

Keyphrases

• Colorectal Adenocarcinoma 100%
• FGFR2 Amplification 100%
• Breast Cancer 66%
• Fibroblast Growth Factor Receptor 2 (FGFR2) 66%
• Gastric Cancer 66%
• Primary Colorectal Cancer 66%
• NCI-H716 Cells 66%
• Clinical Trials 33%
• Tumor 33%
• Tyrosine Kinase Inhibitor 33%
• Colorectal Tumor 33%
• Immunohistochemistry 33%
• Next-generation Sequencing 33%
• In Vitro Activity 33%
• Single nucleotide Polymorphism 33%
• Clinical Sequencing 33%
• Molecular Alterations 33%
• Sequencing Panel 33%
• Tyrosine Kinase Inhibitor Therapy 33%
• Nucleotide Insertion 33%
• Actionable mutations 33%
• Colorectal Cells 33%
• Neuroendocrine Differentiation 33%
• AZD4547 33%
• Copy number Alterations 33%
• Insertion/deletion 33%

Biochemistry, Genetics and Molecular Biology

• Fibroblast Growth Factor Receptor 2 100%
• Tyrosine Kinase Inhibitor 40%
• Clinical Trial 20%
• Single-Nucleotide Polymorphism 20%
• Next Generation Sequencing 20%
• Preclinical Study 20%
• Indel 20%